IT1256178B - Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. - Google Patents

Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Info

Publication number
IT1256178B
IT1256178B ITMI922742A ITMI922742A IT1256178B IT 1256178 B IT1256178 B IT 1256178B IT MI922742 A ITMI922742 A IT MI922742A IT MI922742 A ITMI922742 A IT MI922742A IT 1256178 B IT1256178 B IT 1256178B
Authority
IT
Italy
Prior art keywords
treatment
pharmaceutical compositions
deficiency
glutation
compounds
Prior art date
Application number
ITMI922742A
Other languages
English (en)
Inventor
Lorenzo Ferrari
Original Assignee
Lorenzo Ferrari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lorenzo Ferrari filed Critical Lorenzo Ferrari
Publication of ITMI922742A0 publication Critical patent/ITMI922742A0/it
Priority to ITMI922742A priority Critical patent/IT1256178B/it
Priority to CA002150548A priority patent/CA2150548A1/en
Priority to EP94901919A priority patent/EP0674653B1/en
Priority to ES94901919T priority patent/ES2122221T3/es
Priority to DE69320367T priority patent/DE69320367T2/de
Priority to AT94901919T priority patent/ATE169635T1/de
Priority to PCT/EP1993/003354 priority patent/WO1994012527A1/en
Publication of ITMI922742A1 publication Critical patent/ITMI922742A1/it
Priority to US08/449,802 priority patent/US5736565A/en
Application granted granted Critical
Publication of IT1256178B publication Critical patent/IT1256178B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invenzione riguarda derivati acilati allo zolfo della L-piroglutammilL-cisteina di formula (I) (FORMULA I) dove R è un alchile lineare avente da 1 a 6 atomi di carbonio e i loro sali farmaceuticamente accettabili, il loro procedimento di preparazione e le composizioni farmaceutiche che li contengono. Tali derivati sono utili nel trattamento di malattie connesse ad una carenza di glutatione.
ITMI922742A 1992-11-30 1992-11-30 Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. IT1256178B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITMI922742A IT1256178B (it) 1992-11-30 1992-11-30 Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
DE69320367T DE69320367T2 (de) 1992-11-30 1993-11-30 Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
EP94901919A EP0674653B1 (en) 1992-11-30 1993-11-30 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
ES94901919T ES2122221T3 (es) 1992-11-30 1993-11-30 Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
CA002150548A CA2150548A1 (en) 1992-11-30 1993-11-30 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
AT94901919T ATE169635T1 (de) 1992-11-30 1993-11-30 Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
PCT/EP1993/003354 WO1994012527A1 (en) 1992-11-30 1993-11-30 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
US08/449,802 US5736565A (en) 1992-11-30 1995-05-24 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922742A IT1256178B (it) 1992-11-30 1992-11-30 Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (3)

Publication Number Publication Date
ITMI922742A0 ITMI922742A0 (it) 1992-11-30
ITMI922742A1 ITMI922742A1 (it) 1994-05-30
IT1256178B true IT1256178B (it) 1995-11-29

Family

ID=11364384

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922742A IT1256178B (it) 1992-11-30 1992-11-30 Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Country Status (8)

Country Link
US (1) US5736565A (it)
EP (1) EP0674653B1 (it)
AT (1) ATE169635T1 (it)
CA (1) CA2150548A1 (it)
DE (1) DE69320367T2 (it)
ES (1) ES2122221T3 (it)
IT (1) IT1256178B (it)
WO (1) WO1994012527A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369106B1 (en) 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
US6420429B1 (en) * 1997-12-23 2002-07-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Brain targeted low molecular weight hydrophobic antioxidant compounds
AU728488B2 (en) 1997-04-02 2001-01-11 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect
AU758155B2 (en) 1998-04-29 2003-03-13 Oklahoma Medical Research Foundation Construction of retroviral producer cells from adenoviral and retroviral vectors
DE60234052D1 (de) * 2001-12-18 2009-11-26 Brassica Foundation For Chemop Vorbeugung und behandlung von oxidativer-stress-erkrankungen mit verbindungen die den intrazellulären spiegel von glutathion oder phase-ii-entgiftungsenzymen erhöhen
JP4520089B2 (ja) * 2002-05-31 2010-08-04 サントリーホールディングス株式会社 ルブロフサリン配糖体含有組成物
EP1946750A1 (en) * 2007-01-18 2008-07-23 The Jordanian Pharmaceutical Manufacturing Co. Co-precipitate, method for preparing the same and uses thereof
CA2681593A1 (en) * 2007-03-23 2008-10-02 Nisshin Pharma Inc. Preventive or therapeutic composition for liver disease
US20110183925A1 (en) * 2008-09-22 2011-07-28 Nisshin Pharma Inc. Anti-inflammatory peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT40447A (en) * 1984-03-29 1986-12-28 Sandoz Ag Process for preparing substituted alpha-amino acids and pharmaceutical compositions containing such compounds
IT1216096B (it) * 1988-03-15 1990-02-22 Farmaceutica Italiana S P A S L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico

Also Published As

Publication number Publication date
CA2150548A1 (en) 1994-06-09
ATE169635T1 (de) 1998-08-15
US5736565A (en) 1998-04-07
EP0674653B1 (en) 1998-08-12
WO1994012527A1 (en) 1994-06-09
ITMI922742A1 (it) 1994-05-30
ITMI922742A0 (it) 1992-11-30
ES2122221T3 (es) 1998-12-16
DE69320367T2 (de) 1998-12-17
EP0674653A1 (en) 1995-10-04
DE69320367D1 (de) 1998-09-17

Similar Documents

Publication Publication Date Title
MX9603593A (es) Derivados de quinazolina.
RU94046411A (ru) Производные витамина д, способ их получения, фармацевтическая композиция на их основе и способ ее получения, способ лечения
HUT71551A (en) Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives, process for producing them, and pharmaceutical compositions containing them
HUT68385A (en) Polypeptide and process for producing thereof
MX9205466A (es) Procedimiento para la preparacion de un medicamento para la administracion oral o topica en el tratamiento de leishmaniasis
IT1256178B (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
CA2003289A1 (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
AU5791190A (en) New peptide derivatives, process for preparing them and pharmaceutical compositions containing them
AU4931590A (en) Indole derivatives
AU586477B2 (en) Hexenoic acids
HUP0001866A2 (hu) L-Karnitin és alkanoil-L-karnitin-származékok 2-amino-etánszulfonsavval alkotott sói és ezeket tartalmazó gyógyszerkészítmények
CA2187402A1 (en) Quinoxaline Derivatives for Treating Tinnitus
IT1250625B (it) Derivati dell'eseridina utili per il trattamento delle malattie associaate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1250626B (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
HUT47900A (en) Process for producing new amides of butenic acid and pharmaceutical compositions containing them as active components
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
IT1253007B (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1251228B (it) Derivati della 2-(s)-2-acetil-gicerofosforil-l-serina,composizioni farmaceutiche che li contengono e procedimento per la loro preparazione
IT1248558B (it) Derivati della fisovenina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128